NEKTAR THERAPEUTICS (15) | Separation Agreements (2)
- Employment Transition, Separation and Consultation Agreement, dated as of June 29, 2022, by and between Nektar Therapeutics and John Northcott (Filed With SEC on August 5, 2022)
- Transition, Separation and General Release Agreement, dated as of January 9, 2020, by and between Stephen K. Doberstein and Nektar Therapeutics (Filed With SEC on February 28, 2020)
